Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.0381
Delayed Data
As of Apr 20
 -0.00058 / -1.50%
Today’s Change
0.02
Today|||52-Week Range
0.13
-34.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues24.2K4.3K0.000.00
 
 
 
Cost of Goods Sold15.5K2.2K0.000.00
 
 
 
Depreciation And Amortization15.7K14.8K15.8K14.8K
 
 
 
 
 
 
Operating ExpensesGross Income-7.0K-12.7K-15.8K-14.8K
 
 
 
 
 
General Expenses2.2M2.6M5.4M4.6M
 
 
 
 
 
Research And Development------115.2K
 
 
Total Operating Expenses2.2M2.6M5.4M4.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.6M-5.4M-4.6M
 
 
 
 
 
Extraordinary Credit0.000.002.9M2.6M
 
 
 
Extraordinary Charge0.00-2.7M-363.3K-3.0M
 
 
 
 
Interest Expense On Debt178.8K1.5M2.4M5.8M
 
 
 
 
 
Other Expenses1.4M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-959.5K-6.8M-5.3M-10.8M
 
 
 
 
 
Net Income-959.5K-6.8M-5.3M-10.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS30.3M96.8M117.4M242.1M
 
 
 
 
 
Shares To Calculate EPS Diluted30.3M96.8M117.4M242.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.07-$0.05-$0.04
 
 
 
 
 
EPS Diluted-$0.03-$0.07-$0.05-$0.04